CVS Health Corp (NYSE:CVS) is set to face renewed pressure as hedge fund Glenview Capital Management, led by founder Larry ...

CVS Health's stock remains significantly undervalued by most metrics, even if management are struggling to unlock value.

Hedge fund Glenview Capital Management is set to meet with top executives at CVS Health on Monday to propose operational ...

CVS Health Corp. is conducting a strategic review of options including a possible breakup, Reuters reported, as the company ...

CVS Health executives and hedge fund Glenview Capital Management were reportedly planning to meet today to discuss a shakeup ...

Glenview Capital Management plans to meet Monday with CVS Health Corp. to propose ways for the health-care company to improve its operations, auguring a potential activist push by the hedge fund, the ...

CVS is one of the biggest names in both retail and pharmacy. Whenever you walk into, or drive by, one of the stores, you ...

Repare Therapeutics said it received encouraging early phase 1 data for its camonsertib inhibitor combined with palliative radiation for the treatment of metastatic tumors harboring an ...

Larry Robbins, founder of healthcare-focused Glenview, has established a large position in CVS and owns about 1% of its outstanding shares, the Journal reported. Robbins is expected to meet with Chief ...

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. In the closing of the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...